Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2000
11/07/2000US6143901 Complex formation between dsDNA and pyrrole imidazole polyamides
11/07/2000US6143782 Anti-inflammatory and anti-asthma treatment with reduced side effects
11/07/2000US6143776 Enzyme inhibitors of thymidylate synthase
11/07/2000US6143068 Process for the preparation of highly chromatic perylene pigments
11/02/2000WO2000064583A1 Metal catalysts and methods for making and using same
11/02/2000WO2000064443A1 Synergistic effects of amlodipine and atorvastatin
11/02/2000EP1048649A1 5-arylpyrrole derivatives
11/02/2000EP1048646A1 Process for the continuous distillation of thermolabile monomers
11/02/2000EP1047670A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels
11/02/2000EP1047431A1 Pharmaceutically active compounds and methods of use thereof
11/02/2000EP1047425A1 Integrin receptor antagonists
11/02/2000EP1047410A1 Treatment of glc1a glaucoma with non-steroidal glucocorticoid antagonists
11/02/2000DE19919349A1 Verfahren zur Herstellung eines Benzoylguanidinderivates A method for producing a Benzoylguanidinderivates
11/02/2000CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
11/01/2000CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors
11/01/2000CN1058004C Heterocyclo-benzoylguanidin
10/2000
10/31/2000US6140510 Optically active 3-(1-(carbamoyl))alkyl-2-oxo-pyrrolidines and optically active 3-(1-(alkylamido))alkyl-2-oxo-pyrrolidines
10/31/2000US6140504 Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140358 Substituted phenyl keto enols as pesticides and herbicides
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6140356 Opthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/31/2000US6140345 For treating psychoses and pain
10/31/2000US6140332 Pyrrolopyrimidines and processes for the preparation thereof
10/31/2000US6140137 Metabolite linked to polypeptide for analysis and antibody production; monitoring compliance with methadone treatment
10/26/2000WO2000063169A2 N-dimethyl amino ethanol carboxylate pyrrolidone hydrate in its crystallised form
10/26/2000WO2000063157A1 Disubstituted benzene derivatives
10/26/2000WO2000032188A3 Use of amtolmetin guacyl as an antiinflammatory drug
10/26/2000DE19918568A1 Verfahren zur Herstellung von Pyrrolen A process for the preparation of pyrroles
10/25/2000EP1046639A1 Process for the preparation of pyrroles
10/25/2000EP1046627A2 Enantiopure reagents and process for the separation of enantiomers
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP0720601B1 Gastrin and cck receptor ligands
10/25/2000CN1271342A Synthesis of clasto-lactacystin-beta-lactone and analogs thereof
10/25/2000CN1271341A Substituted 2-pyrolidinone activators of PKC
10/25/2000CN1057755C Fluoroalkenyl compounds and preparing method
10/24/2000US6136983 Pesticidal sulfur compounds
10/24/2000US6136969 Azepanes
10/24/2000US6136844 5-aroylpyrrol-2-ylmethylarene derivatives
10/21/2000CA2305944A1 Process for separating enantiomers and enantiopur reagent
10/19/2000WO2000061783A2 Process for preparing inhibitors of nucleoside metabolism
10/19/2000WO2000061586A1 Bicyclic heteroaromatic compounds useful as lh agonists
10/19/2000WO2000061569A1 Adamantane derivatives
10/19/2000WO2000061552A1 N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-α PRODUCTION INHIBITOR
10/19/2000WO2000061549A2 Pharmaceutical compounds
10/19/2000WO2000061134A1 Antimicrobial agents
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000033788A3 Substituted nitrogen heterocyclic compounds and therapeutic uses thereof
10/19/2000WO2000012507A8 Pyrrolobenzodiazepines
10/19/2000CA2696826A1 Process for preparing inhibitors of nucleoside metabolism
10/19/2000CA2370406A1 Pharmaceutical compounds
10/19/2000CA2369666A1 N-substituted-n'-substituted urea derivatives and the use thereof as tnf-.alpha production inhibitory agents
10/19/2000CA2368829A1 Adamantane derivatives
10/18/2000EP0850215B1 N-(aroyl)glycine hydroxamic acid derivatives and related compounds
10/18/2000CN1270528A Nootropic agent
10/18/2000CN1270166A Derivatives of tricyclo-substituted isohydroxyloxime acid
10/17/2000US6133459 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
10/17/2000US6133457 Process for preparing pharmaceutical compounds
10/17/2000US6133456 Dimers of the macrocyclic natural product, fk506, covalently attached to each other via a synthetic linker moiety
10/17/2000US6133455 Process for the preparation of 2-aryl-5(perfluoro-alkyl) pyrrole compounds from N-(arylmethylene)-1-chloro-1-(perfluoroalkyl) methylamine compounds
10/17/2000US6133308 Synthesis of clasto-lactacystin beta-lactone and analogs thereof
10/17/2000US6133307 2-benzofuran-4-yl-n-(2-(3-hydroxy-pyrrolidin-1-yl)-1-phenyl-ethyl) -n-methyl-acetamide, for example; treatment of arthritis, hypertension, pain, inflammation, migraine, inflammatory gastrointestinal disorders and psoriasis
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6132475 For oxidation dyeing of keratin fibers; includes coupler and developer, in which the developer is a substituted 2-(furyl, thienyl, pyrrolyl, or selenophene) p-diaminobenzene derivative of given formula; colorfastness, washfastness
10/17/2000CA2192396C Bismaleimide compounds and methods for their preparation
10/12/2000WO2000059883A2 Method for producing n-aryl-aza-heterocycles in the presence of cesium carbonate
10/12/2000WO2000059882A1 Anticancer calcium channel blockers
10/12/2000WO2000059880A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000WO2000059878A2 INHIBITORS OF LFA-1 BINDING TO ICAMs AND USES THEREOF
10/12/2000WO2000059876A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059502A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059285A2 NOVEL LACTAM INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO1998025597A3 Method for treating and preventing heart failure and ventricular dilatation
10/12/2000CA2373717A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2369005A1 Inhibitors of lfa-1 binding to icams and uses thereof
10/12/2000CA2368623A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2361848A1 Novel lactam inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2360923A1 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate
10/12/2000CA2268590A1 Ion channel modulating compounds and uses thereof
10/11/2000EP1043312A1 Heterocyclic compounds having nos inhibitory activities
10/11/2000EP1043310A1 Biphenylamidine derivatives
10/11/2000EP1042830A1 Electrochemical cells composite cathodes comprising cationic polymers and electroactive polysulfide compounds
10/11/2000EP1042305A1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1041980A1 Acyl guanidine sodium/proton exchange inhibitors and method
10/11/2000EP0703971B1 Use of n,n-diacetic alpha-alanine and its salts as biodegradable complexing agents for alkaline earth and heavy metal ions in cleaning compositions for dishwashing
10/11/2000EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
10/11/2000CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds
10/11/2000CN1269775A Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
10/11/2000CN1269363A Method for proparing heterocyclic compound
10/11/2000CN1269362A 1,4-dichloropyridine-3,5-carboxylic-acid derivatives and preparation method thereof
10/11/2000CN1269359A Antimer pure acetacetates, its preparation method and use
10/11/2000CN1269358A Amino-butenate compound and preparation method thereof
10/11/2000CN1269357A Benzal compound and preparation method
10/11/2000CN1269136A Fluoric alkenyl compound and use as insect repellent agent
1 ... 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 ... 404